Epigenetic drug ameliorated type 1 diabetes via decreased generation of Th1 and Th17 subsets and restoration of self-tolerance in CD4+ T cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epigenetic drug ameliorated type 1 diabetes via decreased generation of Th1 and Th17 subsets and restoration of self-tolerance in CD4+ T cells
Authors
Keywords
Epigenetics, Self-tolerance, Th1 cells, Th17 cells, Trichostatin A, and Type 1 diabetes
Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 103, Issue -, Pages 108490
Publisher
Elsevier BV
Online
2021-12-24
DOI
10.1016/j.intimp.2021.108490
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The epigenetic drug Trichostatin A ameliorates experimental autoimmune encephalomyelitis via T cell tolerance induction and impaired influx of T cells into the spinal cord
- (2017) Arathi Jayaraman et al. NEUROBIOLOGY OF DISEASE
- Development of the Nonobese Diabetic Mouse and Contribution of Animal Models for Understanding Type 1 Diabetes
- (2017) Yoko Mullen PANCREAS
- Chromogranin A as biomarker in diabetes
- (2016) Kasper Broedbaek et al. Biomarkers in Medicine
- The molecular hallmarks of epigenetic control
- (2016) C. David Allis et al. NATURE REVIEWS GENETICS
- Histone deacetylases: structural determinants of inhibitor selectivity
- (2015) Carmina Micelli et al. DRUG DISCOVERY TODAY
- Cutting Edge: Th1 Cells Facilitate the Entry of Th17 Cells to the Central Nervous System during Experimental Autoimmune Encephalomyelitis
- (2014) R. A. O'Connor et al. JOURNAL OF IMMUNOLOGY
- Double deficiency in IL-17 and IFN-γ signalling significantly suppresses the development of diabetes in the NOD mouse
- (2013) G. Kuriya et al. DIABETOLOGIA
- Transcriptome Analysis of Epigenetically Modulated Genome Indicates Signature Genes in Manifestation of Type 1 Diabetes and Its Prevention in NOD Mice
- (2013) Sundararajan Jayaraman et al. PLoS One
- Chromatin remodeling resets the immune system to protect against autoimmune diabetes in mice
- (2011) Tejas Patel et al. IMMUNOLOGY AND CELL BIOLOGY
- IFN-γ induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice
- (2011) Jun Zhang et al. JOURNAL OF AUTOIMMUNITY
- IL-17 Silencing Does Not Protect Nonobese Diabetic Mice from Autoimmune Diabetes
- (2011) J. Joseph et al. JOURNAL OF IMMUNOLOGY
- Genetic proof for the transient nature of the Th17 phenotype
- (2010) Florian C. Kurschus et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Etiology of Type 1 Diabetes
- (2010) John A. Todd IMMUNITY
- Increased level of exogenous zinc induces cytotoxicity and up-regulates the expression of the ZnT-1 zinc transporter gene in pancreatic cancer cells
- (2010) Arathi K. Jayaraman et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice
- (2009) J. A. Emamaullee et al. DIABETES
- Global estimates of the prevalence of diabetes for 2010 and 2030
- (2009) J.E. Shaw et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells
- (2009) Natalia Martin-Orozco et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice
- (2009) David Bending et al. JOURNAL OF CLINICAL INVESTIGATION
- Innocuous IFNγ induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production
- (2008) Renu Jain et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More